Scarica l'app Stockscreener
23.50
0.64%
0.15
Dopo l'orario di chiusura:
23.85
0.35
+1.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$23.35
Aprire:
$23.21
Volume 24 ore:
486.47K
Relative Volume:
0.80
Capitalizzazione di mercato:
$1.16B
Reddito:
$723.55M
Utile/perdita netta:
$157.72M
Rapporto P/E:
7.8333
EPS:
3
Flusso di cassa netto:
$170.15M
1 W Prestazione:
-3.77%
1M Prestazione:
-16.93%
6M Prestazione:
-53.76%
1 anno Prestazione:
-41.26%
Intervallo 1D:
$22.84
$23.59
Intervallo di 1 settimana:
$22.64
$24.92
Portata 52W:
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
23.50 | 1.16B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.64B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com
U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com
JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat
Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa
Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Australia
Portolan Capital Management LLC Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey
2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance
Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World
Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com
Federated Hermes Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Renaissance Group LLC Has $3.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowShould You Sell? - MarketBeat
Needham & Company LLC Reiterates Hold Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Dynamic Technology Lab Private Ltd Acquires 14,468 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Glucagon Market Set to Witness Significant Growth by 2032 | Eli - openPR.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Increased by Vanguard Group Inc. - Defense World
Trexquant Investment LP Buys 16,248 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar at Needham Conference: Strategic Growth Amidst Challenges By Investing.com - Investing.com Canada
Amphastar stock hits 52-week low at $25.72 amid market challenges - Investing.com Australia
Amphastar stock hits 52-week low at $25.72 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of Stock - MarketBeat
Corebridge Financial Inc. Sells 1,613 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 3.1%Should You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by American Century Companies Inc. - MarketBeat
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021 - ACCESS Newswire
We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Stay On Top Of Its Debt - simplywall.st
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023 - ACCESS Newswire
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - ACCESS Newswire
Amphastar Leadership Team Set for Major Investor Presentation at Needham Conference - Stock Titan
Amphastar Pharmaceuticals director sells $14,190 in stock - Investing.com India
Amphastar Pharmaceuticals director sells $14,190 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022 - ACCESS Newswire
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):